Co-Stone Leads $27.9 M Series B Round In Gene Testing Firm Gene+ Technology

Gene+ Technology, providing gene testing service for cancer prevention, announced it raised RMB200 million (US$27.9 million) in a series B funding round led by Chinese private equity investment firm Co-Stone Asset Management Co., Ltd on September 30. Shenzhen-based genome sequencing company BGI Group, Shanghai-based investment firm Volcanics Venture, Shenzhen-based investment firm Green Pine Capital Partners, […]

Co-Stone Leads $27.9 M Series B Round In Gene Testing Firm Gene+ Technology comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network